LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.39 | 21.74 | 3325 | 6112 | 0.5439 | 0.8558 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.36 | 21.74 | 354 | 6191 | 0.0572 | 0.4080 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.36 | 21.74 | 3807 | 6191 | 0.6149 | 0.8842 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.36 | 21.74 | 33 | 6191 | 0.0053 | 0.0525 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.36 | 21.74 | 3511 | 6191 | 0.5671 | 0.8656 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.33 | 21.74 | 380 | 6235 | 0.0609 | 0.4197 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.33 | 21.74 | 4019 | 6235 | 0.6445 | 0.8952 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.33 | 21.74 | 23 | 6235 | 0.0037 | 0.0069 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.33 | 21.74 | 3753 | 6235 | 0.6019 | 0.8794 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.30 | 21.74 | 455 | 6244 | 0.0729 | 0.4512 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.30 | 21.74 | 4239 | 6244 | 0.6788 | 0.9073 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.30 | 21.74 | 25 | 6244 | 0.0040 | 0.0173 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.30 | 21.74 | 3965 | 6244 | 0.6349 | 0.8918 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.27 | 21.74 | 521 | 6201 | 0.0840 | 0.4762 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.27 | 21.74 | 4454 | 6201 | 0.7182 | 0.9205 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.27 | 21.74 | 12 | 6201 | 0.0019 | -0.0703 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.27 | 21.74 | 4110 | 6201 | 0.6627 | 0.9016 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.24 | 21.74 | 592 | 6162 | 0.0961 | 0.5002 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.24 | 21.74 | 4635 | 6162 | 0.7522 | 0.9313 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.24 | 21.74 | 7 | 6162 | 0.0011 | -0.1299 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.24 | 21.74 | 4300 | 6162 | 0.6978 | 0.9136 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.21 | 21.74 | 532 | 6235 | 0.0853 | 0.4794 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.21 | 21.74 | 4783 | 6235 | 0.7671 | 0.9361 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.21 | 21.74 | 12 | 6235 | 0.0019 | -0.0702 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.21 | 21.74 | 4473 | 6235 | 0.7173 | 0.9203 | MN20160310_N01 | L15 |